With over 20 years of experience at the intersection of intellectual property and technology transactions, Michael Orlando is a strategic counselor to innovators and enterprises navigating complex technology and IP challenges. He is Team Leader of the firm's Technology Transactions Team, and a member of the Artificial Intelligence, Life Sciences and Healthcare teams. Michael also co-leads the firm’s Digital Health & Innovation team and is the host of Sheppard’s Health-e Law podcast.
Michael founded a software-as-a-service (SaaS) business prior to entering private practice, and completed an in-house secondment at a publicly-traded biotechnology company. This real-world experience as both a tech entrepreneur and in-house counsel gives him unique insight to understand his clients' business objectives and informs his practical, business-oriented approach to solving a wide variety of technology issues.
Michael helps cutting-edge technology companies and innovators develop, commercialize, and procure technology, including in connection with licensing, outsourcing, joint ventures, mergers and acquisitions, venture financing, collaborations, strategic partnerships and commercial agreements. His cross-disciplinary expertise in both intellectual property and corporate transactions allows him to leverage both practice areas when advising his clients.
Michael's legal practice spans multiple industries, including high-tech, biotechnology/pharmaceuticals, medical devices, digital health and healthcare IT, data centers, energy, aerospace, and automotive technologies, including electric, autonomous and connected vehicle technologies.
Throughout his career, Michael has assisted both start-ups and Fortune 500 companies, including some of the world’s largest technology providers, with various types of transactions and commercial arrangements, including:
- patent and know-how licenses, research, development and strategic collaboration agreements, co-promotion agreements, clinical trial agreements, and supply, manufacturing, distribution, logistics and other outsourcing agreements for pharmaceutical, biotechnology and medical device companies, including for pre-clinical, clinical, and commercial products.
- Telehealth services agreements, wearable device and remote patient monitoring agreements, mobile health application terms of service, data use agreements, healthcare information exchange agreements, revenue cycle management agreements, EHR system procurement, installation and services agreements, medical device and durable medical equipment procurement, artificial intelligence (AI) tools and AI governance frameworks, clinical decision support tools, interoperability, technology development, strategic collaborations and joint ventures for digital health technology companies, health insurers (payers), healthcare systems and physician organizations (providers).
- software and hardware technology licenses, IT procurement agreements, SaaS/PaaS/IaaS agreements, Service Level Agreements, maintenance and support agreements, data center service agreements, cloud migration and digital transformation agreements, software escrows, open source licenses, generative AI/LLM licensing, API licenses, connected (IOT) device agreements, joint development agreement, and OEM, VAR, reseller and distribution agreements.
- outsourcing agreements, including information technology outsourcing (ITO), managed service agreements, business process outsourcing (BPO), outsourced development, manufacturing and supply agreements, and offshoring arrangements.
